NASDAQ Biotechnology
ショート

#Nasdaq #Biotech It ought to correct overbought

134
It ought to correct overbought Nasdaq Biotechnology Index:
The Nasdaq Biotech index has grown about 50 percent since Yellen's valuation comments. Superarando por mucho el desempeño de los indices composite y S&P500, this boom is due primarily to the pharmaceutical companies who have monopolized the attention of investors the past few months, beyond the debate of whether exist a bubble formation the Nasdaq Biotechnology Index It ought to correct their overbought at least 6% as it has done in later months

bloomberg.com/news/articles/2015-03-20/biotech-has-surged-massively-since-warning-from-the-fed

免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。